Inovio Pharmaceuticals Inc (INO) stock news · rev $65.3K
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
This INO news page leads with what Inovio Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for INO yet. We will not pad this page with generic market recap.
Latest reported INO revenue for 2025-12-31 was $65.3K. Net income was -$84.9M. Revenue was down 70.0% from 2024-12-31 to 2025-12-31. INO currently screens at market cap $88.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the INO stock page; for the tape open the quote page.
INO stock news FAQ
What are INO's latest revenue and net income?
Latest cached Inovio Pharmaceuticals Inc (INO) revenue for Dec 31, 2025 was $65.3K. Net income was -$84.9M. Statements: https://lician.com/financials/ino
How did INO revenue change from the prior cached period?
Cached Inovio Pharmaceuticals Inc (INO) revenue was down 70.0% from $217.8K (Dec 31, 2024) to $65.3K (Dec 31, 2025). Statements: https://lician.com/financials/ino
What is INO's market cap?
Inovio Pharmaceuticals Inc (INO) market cap is $88.0M on the latest cached fundamentals snapshot.
What kind of company is INO?
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Where is INO stock news listed?
Cached stock news for Inovio Pharmaceuticals Inc (INO) is listed at https://lician.com/news/ino. Filings: https://lician.com/sec/ino
Not investment advice.